CING (Cingulate Inc) Market Value to Book Value Ratio

Cingulate Inc. (CING) operates primarily in the US market, yet the company remains vulnerable due to its procurement of components from India and China. This chart illustrates that the asset's market value on the GURU.Markets platform is currently 3.06. The business develops innovative controlled-release ADHD treatments, ensuring a steady emotional state for patients and a consistent therapeutic effect.

For Cingulate Inc., which invests in the intellectual capital of chemists and pharmacologists, this ratio determines the market value of assets relative to their book value. The metric is calculated by dividing the market capitalization by the equity on the balance sheet. By analyzing this chart of the market cap to book value multiple, an investor can see the premium for future innovations in ADHD treatment. A wide gap signals growth expectations, however, an excessive imbalance increases investment risks.